Quarterly report pursuant to Section 13 or 15(d)

Business (Details)

v3.24.1.1.u2
Business (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Mar. 28, 2024
Mar. 31, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Debt Instrument [Line Items]          
Proceeds from issuance of common stock $ 108,100        
Net loss     $ 121,283 $ 9,947  
Net cash used in operating activities     (6,202) (10,052)  
Cash and cash equivalents   $ 110,177 110,177 16,687 $ 7,415
Proceeds from sale of shares pursuant to common stock private placement, net     115,625 $ 0  
Private Placement          
Debt Instrument [Line Items]          
Net proceeds 185,000 185,000      
Proceeds from sale of shares pursuant to common stock private placement, net 108,100 108,100      
Private Placement | Preferred Stock          
Debt Instrument [Line Items]          
Net proceeds 115,600 115,600      
Private Placement | Warrant liability          
Debt Instrument [Line Items]          
Fair value of warrant $ 69,400 $ 69,400 $ 69,400